Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Ribavirin

A synthetic guanosine analogue antiviral, synthesised in the early 1970s and approved for medical use in 1986: it is used for hepatitis C, combined with other drugs, and for some viral haemorrhagic fevers such as Lassa fever. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards and other impurities.

Did you know?One of its mechanisms is surprising: once built into the virus's RNA it multiplies copying errors, pushing the virus towards an 'error catastrophe' that leaves it unable to replicate.

RibavirinGo to the active ingredient →
RibavirinActive ingredientRibavirinCat. No. P-R048-001CAS 36791-04-5
Ribavirin-13C2Isotopically labelledRibavirin-13C2Cat. No. P-R048-011CAS 1279035-36-7
Ribavirin-13C5Isotopically labelledRibavirin-13C5Cat. No. P-R048-012CAS 1646818-35-0

EDQM standards 1

The official European Pharmacopoeia standards for this family.

Reference substanceRibavirin CRSEDQM code Y0000377Family Ribavirin

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.